Stay updated on Nivolumab Combos in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combos in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Combos in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA minor UI update now displays Revision: v3.4.2 instead of Revision: v3.4.1, with no changes to study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. No other content or layout changes are apparent in the screenshots and page text.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision label updated to v3.3.4, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedLocations section updated with new site regions (Texas; New South Wales; Queensland; North Rhine-Westphalia; PG; PN; Andalusia; Catalonia; Valencia). The footer revision tag changed from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.9%

- Check90 days agoChange DetectedAdded a clarifying note that PubMed auto-fill publications may not be about the study, and updated the page revision label to v3.3.2; the older PubMed description text was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check98 days agoChange DetectedThe notice about a lapse in government funding and related operating-status information was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Combos in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combos in NSCLC Clinical Trial page.